ĐÁNH GIÁ KẾT QUẢ PHẪU THUẬT NỘI SOI TUYẾN GIÁP QUA ĐƯỜNG MIỆNG TẠI BỆNH VIỆN ĐẠI HỌC Y HÀ NỘI

Abstract

Objects: Our study aims to evaluate of Treatment Outcomes for TOETVA at Hanoi University Hospital from January 2020 to December 2022. Subjects and methods: A cross-sectinal study was conducted on 731 patients undergone transoral endoscopic thyroidectomy vestibular approach at Hanoi University Hospital from January 2020 to December 2022. Results: The study was conducted on 731 patients. Females accounted for 96.4%, while males constituted 3.6%. The average age was 35.4 ± 9.2 (8-59) years. The patients with postoperative histopathological results indicating thyroid cancer was 73.9%, and those with benign results were 26.1%. Surgical procedures involving lobectomy and ipsilateral central neck lymph node dissection comprised 67.7% of cases, total thyroidectomy and bilateral central neck lymph node dissection was appiled in 5.9% of cases. Lobectomy was performed in 145 patients (19.8%), and total thyroidectomy in 48 patients (6.6%). There were no cases converted to open surgery. The operation time of lobectomy, total thyroidectomy, total thyroidectomy with bilateral central neck lymph node dissection, and lobectomy with ipsilateral central neck lymph node dissection were 86.1±25.4, 115±5.1, 120.5±18.3, and 95.2±2.6 minutes, respectively. The hospitalization time was 5.4±1.8 (3-8) days. No cases of enduring postoperative complications were recorded, and the rate of temporary complications was exceptionally low, with patients recovering within six months after surgery. Conclusion: TOETVA is a safe method for patients with thyroid nodules including benign and malignant tumors.